Business Context and Reporting Period
This Form 8-K was filed by Glucotrack, Inc. on November 22, 2022, reporting a material event regarding its continued listing status on the Nasdaq stock exchange. The company is incorporated in Delaware and maintains its principal executive offices in Or Yehuda, Israel.
Key Financial Metrics
The filing references specific financial data from the Company's 10-Q for the period ended September 30, 2022, to justify the delisting notice:
- Stockholders' Equity: $2,355,000 (as of September 30, 2022).
- Required Minimum Equity: $2,500,000 (per Nasdaq Listing Rule 5550(b)(1)).
- Net Income/Market Value: The filing states the Company does not meet the alternative compliance standards regarding market value of listed securities or net income from continuing operations.
The filing text does not provide clear values for revenue, cash flow, operating margins, or total debt.
Material Changes
The primary material change is the Company's failure to satisfy Nasdaq's continued listing requirements. Specifically, the reported stockholders' equity of $2,355,000 falls below the mandated minimum of $2,500,000. Additionally, the Company failed to qualify for alternative compliance measures based on market value or net income.
Outlook, Risks, and Contingencies
Delisting Risk: The Company faces an immediate risk of delisting from Nasdaq due to non-compliance with equity requirements.
Compliance Plan: The Company has been granted a 45-day period, ending on January 6, 2023, to submit a plan of compliance to Nasdaq to restore its listing status.
Management Commentary: The filing contains no forward-looking guidance, revenue outlook, or management commentary beyond the factual notice of the delisting and the compliance deadline.
Investor Verification Checklist
- Verify the Company's current stockholders' equity as of the most recent financial statement to confirm the deficit against the $2.5 million threshold.
- Monitor the submission of the compliance plan to Nasdaq by the January 6, 2023 deadline.
- Review the Company's 10-Q for the period ended September 30, 2022, for detailed financial statements regarding net income and cash flow.
- Check for any subsequent filings regarding the acceptance or rejection of the compliance plan by Nasdaq.